Complexa, Inc.: Clinical Trials

9 trials sponsored by Complexa, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 terminated. 5 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 5
Phase 24Terminated 3, Completed 1

Follow Complexa, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral CXA-10 in Pulmonary Arterial Hypertension
CXA-10 - Pulmonary Arterial Hypertension
Phase 2TerminatedGladwin, Mark, MD12019-10-312022-01-12
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
CXA-10 - PAH
Phase 2TerminatedComplexa, Inc.332019-08-092020-08-26
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
75mg CXA-10, 150mg CXA-10, Placebo - PAH
Phase 2TerminatedComplexa, Inc.692018-08-012020-08-10
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
CXA-10 - Primary Focal Segmental Glomerulosclerosis
Phase 2CompletedComplexa, Inc.332018-04-152020-08-03
A Study of the PK Interaction of CXA-10 With Pravastatin and Vytorin® in Healthy Males
CXA-10, pravastatin, Vytorin® (combination of simvastatin and ezetimibe) - Acute Kidney Injury
Phase 1CompletedComplexa, Inc.102015-12-012016-05-03
PK and PD of Sequential Multiple Ascending, Repeat Doses of Oral CXA-10 in Healthy Obese Male Subjects
CXA-10, CXA-10 placebo - Acute Kidney Injury
Phase 1CompletedComplexa, Inc.432015-04-012016-05-03
Oral CXA-10 Study in Healthy Volunteers
CXA-10, CXA-10 placebo - Chronic Kidney Injury
Phase 1CompletedComplexa, Inc.402015-01-012016-05-03
Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury
CXA-10 - Acute Kidney Injury (Nontraumatic)
Phase 1CompletedComplexa, Inc.122014-09-012018-02-01
Study of CXA-10 in Healthy Volunteers
CXA-10 emulsion, Placebo - Acute Kidney Injury (Nontraumatic)
Phase 1CompletedComplexa, Inc.302014-04-012018-02-01

Conditions studied

Acute Kidney Injury (4)  ·  Pulmonary Arterial Hypertension (3)  ·  Cardiovascular Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Familial Primary Pulmonary Hypertension (2)  ·  Hypertension (2)  ·  Hypertension, Pulmonary (2)  ·  Lung Diseases (2)  ·  Vascular Diseases (2)  ·  Kidney Diseases (1)  ·  Nephrotic Syndrome (1)  ·  Proteinuria (1)

Interventions

CXA-10 (8)  ·  Ezetimibe (1)  ·  Ezetimibe, Simvastatin Drug Combination (1)  ·  Pravastatin (1)

Countries

United States (9)  ·  United Kingdom (2)

Top investigators

Thomas Blok, MD (3)  ·  Theo Danoff, MD (2)  ·  James VanderLugt, MD (1)  ·  Marc Simon, MD (1)  ·  Theodore Danoff, MD (1)

NIH funding

P01HL103455 (1)